Avantor, Inc. Restructuring and Related Cost, Incurred Cost
Avantor, Inc. (AVTR) reported Restructuring and Related Cost, Incurred Cost of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2025-10-29
- Avantor, Inc. restructuring and related cost, incurred cost for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Avantor, Inc. restructuring and related cost, incurred cost for the quarter ending 2024-09-30 was $49.40M.
| Period end | Restructuring and Related Cost, Incurred Cost 3 month | Restructuring and Related Cost, Incurred Cost 9 month |
|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-10-29 | $0.00 10-Q · filed 2025-10-29 |
| 2024-09-30 | $49.40M 10-Q · filed 2025-10-29 | $82.30M 10-Q · filed 2025-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |